AG
SPPI

Algert Global’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Algert Global’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-28,851
Closed -$190K – 454
2016
Q2 		$190K Buy
+28,851
New +$204K 0.08% 327
2015
Q2 		– Sell
-16,700
Closed -$101K – 373
2015
Q1 		$101K Hold
16,700
– – 0.06% 299
2014
Q4 		$116K Buy
+16,700
New +$123K 0.07% 277

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Algert Global's SPPI Position: Q3 2016 in Review

Algert Global sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2016, closing a stake of 28,851 shares — an estimated $190K sold.

Algert Global first reported a position in SPPI in Q4 2014 and held it in 3 quarters. The position peaked at $190K in Q2 2016. 144 funds tracked by Wall St. Rank hold SPPI as of Q3 2016.

  • Algert Global reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Algert Global sold 28,851 Spectrum Pharmaceuticals Inc shares in Q3 2016, an estimated $190K.
  • Algert Global first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 3 quarters.
  • Algert Global's Spectrum Pharmaceuticals Inc position peaked at $190K in Q2 2016.
  • 144 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2016.

Based on Algert Global's 13F filing for Q3 2016, filed 12 Oct 2016.